Companies

Surrozen, Inc./DE (SRZN) SEC filings

CIK 0001824893 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)3.5 M0
Net income (USD)-242.0 M-43.0 M-36.0 M
Diluted EPS (USD/shares)-32.37-21.33-15.56

Latest filings

FiledFormDescriptionPeriod
2026-10-208-K8-K items 2.02,3.02,9.012026-10-20
2026-10-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-028-K8-K items 8.012026-10-02
2026-10-01SCHEDULE 13GSCHEDULE 13G
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-11SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0725-NSE25-NSE
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.022026-08-06
2026-07-24SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-24442026-07-22
2026-06-16442026-06-15
2026-06-16442026-06-15
2026-06-16442026-06-15
2026-06-16442026-06-15
2026-05-19442026-05-13
2026-05-18SCHEDULE 13D/ASCHEDULE 13D/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 142, 8-K 59, 424B3 29, 3 27, SCHEDULE 13G/A 26, CORRESP 19, 10-Q 18, SCHEDULE 13G 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=SRZN (0.002 USD), /gw/filings/filings?ticker=SRZN&form=8-K, /gw/filings/facts?ticker=SRZN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange